These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28692176)

  • 1. Phenotypic spectrum associated with de novo mutations in QRICH1 gene.
    Ververi A; Splitt M; Dean JCS; ; Brady AF
    Clin Genet; 2018 Feb; 93(2):286-292. PubMed ID: 28692176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRICH1 mutations cause a chondrodysplasia with developmental delay.
    Lui JC; Jee YH; Lee A; Yue S; Wagner J; Donnelly DE; Vogt KS; Baron J
    Clin Genet; 2019 Jan; 95(1):160-164. PubMed ID: 30281152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QRICH1 variants in Ververi-Brady syndrome-delineation of the genotypic and phenotypic spectrum.
    Föhrenbach M; Jamra RA; Borkhardt A; Brozou T; Muschke P; Popp B; Rey LK; Schaper J; Surowy H; Zenker M; Zweier C; Wieczorek D; Redler S
    Clin Genet; 2021 Jan; 99(1):199-207. PubMed ID: 33009816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel variant in the QRICH1 gene was identified in a patient with severe developmental delay.
    Wang D; Wu J
    Mol Genet Genomic Med; 2023 Aug; 11(8):e2227. PubMed ID: 37331002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
    DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
    J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of Ververi-Brady syndrome due to QRICH1 loss of function and the literature review.
    Baruch Y; Horn-Saban S; Plotsky Y; Bercovich D; Gershoni-Baruch R
    Am J Med Genet A; 2021 Jun; 185(6):1913-1917. PubMed ID: 33738978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
    Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK
    Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with
    Balasubramanian M; Willoughby J; Fry AE; Weber A; Firth HV; Deshpande C; Berg JN; Chandler K; Metcalfe KA; Lam W; Pilz DT; Tomkins S
    J Med Genet; 2017 Aug; 54(8):537-543. PubMed ID: 28100473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Variants Associated With Developmental Disability: Exome sequencing data findings implicate new genes as potential sources of de novo mutations.
    Am J Med Genet A; 2017 May; 173(5):1139-1140. PubMed ID: 28421702
    [No Abstract]   [Full Text] [Related]  

  • 12. Whole Exome Sequencing Reveals a BSCL2 Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient.
    Alaei MR; Talebi S; Ghofrani M; Taghizadeh M; Keramatipour M
    Iran Biomed J; 2016 Nov; 20(5):295-301. PubMed ID: 27452399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo loss-of-function variants of ASH1L are associated with an emergent neurodevelopmental disorder.
    Shen W; Krautscheid P; Rutz AM; Bayrak-Toydemir P; Dugan SL
    Eur J Med Genet; 2019 Jan; 62(1):55-60. PubMed ID: 29753921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.
    Venkateswaran S; Myers KA; Smith AC; Beaulieu CL; Schwartzentruber JA; ; Majewski J; Bulman D; Boycott KM; Dyment DA
    Epilepsia; 2014 Jul; 55(7):e75-9. PubMed ID: 24903190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
    Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
    Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Utility of Next-Generation Sequencing for Developmental Disorders in the Rehabilitation Department: Experiences from a Single Chinese Center.
    Liu Y; Liu X; Qin D; Zhao Y; Cao X; Deng X; Cheng Y; Liu F; Yang F; Zhang T; Yang XA
    J Mol Neurosci; 2021 Apr; 71(4):845-853. PubMed ID: 32959227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
    Kataoka M; Matoba N; Sawada T; Kazuno AA; Ishiwata M; Fujii K; Matsuo K; Takata A; Kato T
    Mol Psychiatry; 2016 Jul; 21(7):885-93. PubMed ID: 27217147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trio-based exome sequencing arrests de novo mutations in early-onset high myopia.
    Jin ZB; Wu J; Huang XF; Feng CY; Cai XB; Mao JY; Xiang L; Wu KC; Xiao X; Kloss BA; Li Z; Liu Z; Huang S; Shen M; Cheng FF; Cheng XW; Zheng ZL; Chen X; Zhuang W; Zhang Q; Young TL; Xie T; Lu F; Qu J
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4219-4224. PubMed ID: 28373534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.